Cancer BiologybioRxiv
Kinome rewiring reveals AURKA is a molecular barrier to the efficacy of PI3K/mTOR-pathway inhibitors in breast cancer
H. J. Donnella, J. T. Webber, R. S. Levin…·S. Bandyopadhyay
The paper identifies AURKA as a barrier to PI3K/mTOR inhibitor efficacy in breast cancer by mapping kinome dynamics and showing that AURKA inhibition synergizes with these drugs to induce apoptosis and tumor regression.
DOI 10.1038/s41589-018-0081-9